Haiying Sun, Ph.D - Publications

1997-2000 SIOC,CAS 
 2014- China Pharmaceutical University 

74 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Sun H, Ning R, Xu D, Tang F. Reply from Sun et al. Journal of the American Geriatrics Society. PMID 32710458 DOI: 10.1111/jgs.16760  0.44
2020 Sun H, Ning R, Tao Y, Yu C, Deng X, Zhao C, Meng S, Xu D, Tang F. Comparison of clinical and microbiological diagnoses for older adults with COVID-19 in Wuhan: a retrospective study. Aging Clinical and Experimental Research. PMID 32638344 DOI: 10.1007/s40520-020-01647-4  0.44
2020 Sang W, Shi M, Yang J, Cao J, Xu L, Yan D, Yao M, Liu H, Li W, Zhang B, Sun K, Song X, Sun C, Jiao J, Qin Y, ... ... Sun H, et al. Phase II trial of co-administration of CD19- and CD20-targeted chimeric antigen receptor T cells for relapsed and refractory diffuse large B cell lymphoma. Cancer Medicine. PMID 32608579 DOI: 10.1002/cam4.3259  0.36
2020 Wu H, Sun H, He Z, Chen X, Li Y, Zhao X, Kong W, Kong W. The effect and mechanism of 19S proteasome PSMD11/Rpn6 subunit in D-Galactose induced mimetic aging models. Experimental Cell Research. 112093. PMID 32450067 DOI: 10.1016/j.yexcr.2020.112093  0.32
2020 Li H, Yin L, Wang Y, Wang X, Shi M, Cao J, Yan Z, Sang W, Cheng H, Zhu F, Sun H, Li D, Jing G, Zheng J, Li Z, et al. Safety and efficacy of chimeric antigen receptor T-cell therapy in relapsed/refractory multiple myeloma with renal impairment. Bone Marrow Transplantation. PMID 32388534 DOI: 10.1038/s41409-020-0930-5  0.48
2020 Sun H, Ning R, Tao Y, Yu C, Deng X, Zhao C, Meng S, Tang F, Xu D. Risk factors for mortality in 244 older adults with COVID-19 in Wuhan, China: a retrospective study. Journal of the American Geriatrics Society. PMID 32383809 DOI: 10.1111/jgs.16533  0.44
2020 Zhu F, Qiu T, Zhu S, Zhao K, Chen C, Qiao J, Pan B, Yan Z, Chen W, Liu Q, Wu Q, Cao J, Sang W, Zeng L, Sun H, et al. TIRC7 inhibits Th1 cells by upregulating the expression of CTLA‑4 and STAT3 in mice with acute graft‑versus‑host disease. Oncology Reports. PMID 32319655 DOI: 10.3892/or.2020.7588  0.36
2020 Han B, Yang X, Zhang P, Zhang Y, Tu Y, He Z, Li Y, Yuan J, Dong Y, Hosseini DK, Zhou T, Sun H. DNA methylation biomarkers for nasopharyngeal carcinoma. Plos One. 15: e0230524. PMID 32271791 DOI: 10.1371/journal.pone.0230524  0.32
2020 Naing A, Gainor JF, Gelderblom H, Forde PM, Butler MO, Lin CC, Sharma S, Ochoa de Olza M, Varga A, Taylor M, Schellens JHM, Wu H, Sun H, Silva AP, Faris J, et al. A first-in-human phase 1 dose escalation study of spartalizumab (PDR001), an anti-PD-1 antibody, in patients with advanced solid tumors. Journal For Immunotherapy of Cancer. 8. PMID 32179633 DOI: 10.1136/jitc-2020-000530  0.32
2020 Cai H, Han B, Hu Y, Zhao X, He Z, Chen X, Sun H, Yuan J, Li Y, Yang X, Kong W, Kong WJ. Metformin attenuates the D‑galactose‑induced aging process via the UPR through the AMPK/ERK1/2 signaling pathways. International Journal of Molecular Medicine. PMID 31922237 DOI: 10.3892/ijmm.2020.4453  0.32
2019 Sun H, Jiang J, Gong L, Li X, Yang Y, Luo Y, Guo Z, Lu R, Li H, Li J, Zhao J, Yang N, Li Y. Voltage-gated sodium channel inhibitor reduces atherosclerosis by modulating monocyte/macrophage subsets and suppressing macrophage proliferation. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie. 120: 109352. PMID 31586905 DOI: 10.1016/j.biopha.2019.109352  0.44
2019 Han B, Zhou T, Tu Y, Wang T, He Z, Li Y, Yuan J, Yang X, Sun H. Correlation between mitochondrial DNA 4977 bp deletion and presbycusis: A system review and meta-analysis. Medicine. 98: e16302. PMID 31277167 DOI: 10.1097/MD.0000000000016302  0.32
2019 Han B, Yang X, Li Y, Hosseini DK, Tu Y, Dong Y, He Z, Yuan J, Cai H, Zhang K, Zhang X, Zhou T, Sun H. Association of polymorphisms in grainyhead-like-2 gene with the susceptibility to age-related hearing loss: A systematic review and meta-analysis. Medicine. 98: e16128. PMID 31232964 DOI: 10.1097/MD.0000000000016128  0.32
2019 Sun H, Yu J, Wen Z, Wang M, Chen W. Decreased expression of Beclin-1 in patients with hepatocellular carcinoma. Journal of B.U.On. : Official Journal of the Balkan Union of Oncology. 24: 634-641. PMID 31128017  0.44
2019 Chen J, Chen X, Chen X, Sun H, Yang D. SM‑164 enhances the antitumor activity of adriamycin in human U2‑OS cells via downregulation of X‑linked inhibitor of apoptosis protein. Molecular Medicine Reports. PMID 31059038 DOI: 10.3892/mmr.2019.10181  0.32
2019 Li J, Xi W, Li X, Sun H, Li Y. Advances in inhibition of protein-protein interactions targeting hypoxia-inducible factor-1 for cancer therapy. Bioorganic & Medicinal Chemistry. PMID 30819620 DOI: 10.1016/j.bmc.2019.01.042  0.44
2019 Tu Y, Fan G, Sun H, Cai X, Kong W. Endoplasmic reticulum stress is involved in spiral ganglion neuron apoptosis following chronic kanamycin-induced deafness. Bioscience Reports. PMID 30626727 DOI: 10.1042/BSR20181749  0.32
2018 Li Y, Zhao X, Hu Y, Sun H, He Z, Yuan J, Cai H, Sun Y, Huang X, Kong W, Kong W. Age-associated decline in Nrf2 signaling and associated mtDNA damage may be involved in the degeneration of the auditory cortex: Implications for central presbycusis. International Journal of Molecular Medicine. PMID 30272261 DOI: 10.3892/ijmm.2018.3907  0.32
2018 Du L, Grigsby SM, Yao A, Chang Y, Johnson G, Sun H, Nikolovska-Coleska Z. Peptidomimetics for Targeting Protein-Protein Interactions between DOT1L and MLL Oncofusion Proteins AF9 and ENL. Acs Medicinal Chemistry Letters. 9: 895-900. PMID 30258537 DOI: 10.1021/acsmedchemlett.8b00175  0.36
2018 Xia J, Sun H, Yan Z, Zhu F, Zhao K, Xu K. Successful treatment of a patient with Philadelphia chromosome-positive acute lymphoblastic leukemia complicated by bone marrow necrosis and acute renal insufficiency: A case report. Molecular and Clinical Oncology. 9: 297-301. PMID 30112174 DOI: 10.3892/mco.2018.1661  0.36
2018 Tu Y, Fan G, Xi H, Zeng T, Sun H, Cai X, Kong W. Identification of candidate aberrantly methylated and differentially expressed genes in thyroid cancer. Journal of Cellular Biochemistry. PMID 30069928 DOI: 10.1002/jcb.27129  0.32
2018 Chen X, Liu L, Chen Y, Yang Y, Yang CY, Guo T, Lei M, Sun H, Wang S. Cyclic Peptidic Mimetics of Apollo Peptides Targeting Telomeric Repeat Binding Factor 2 (TRF2) and Apollo Interaction. Acs Medicinal Chemistry Letters. 9: 507-511. PMID 29795768 DOI: 10.1021/acsmedchemlett.8b00152  0.44
2018 Sun H, Huang K, Tang F, Li X, Wang X, Long S, Zhou S, Suolangquzhen, Zhang J, Ning R, Li S, Wang S, Ma D. Adjuvant chemotherapy after surgery can improve clinical outcomes for patients with IB2-IIB cervical cancer with neoadjuvant chemotherapy followed by radical surgery. Scientific Reports. 8: 6443. PMID 29691415 DOI: 10.1038/s41598-018-24413-z  0.48
2018 Liu J, Sun H, Shen D, Wang M, Wen Z. Antitumor effect of membrane-type Tim-3 on hepatocellular carcinoma Hepa1-6 cells of ICR mice. Oncology Letters. 15: 2631-2634. PMID 29434984 DOI: 10.3892/ol.2017.7620  0.44
2018 Yuan J, Zhao X, Hu Y, Sun H, Gong G, Huang X, Chen X, Xia M, Sun C, Huang Q, Sun Y, Kong W, Kong W. Autophagy regulates the degeneration of the auditory cortex through the AMPK-mTOR-ULK1 signaling pathway. International Journal of Molecular Medicine. PMID 29344647 DOI: 10.3892/ijmm.2018.3393  0.32
2017 Meng G, Li C, Sun H, Lee I. Multiple Calcium Patterns of Rat Osteoblasts under Fluidic Shear Stress. Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society. PMID 29266507 DOI: 10.1002/jor.23843  0.48
2017 Chen X, Zhao X, Lan F, Zhou T, Cai H, Sun H, Kong W, Kong W. Hydrogen Sulphide Treatment Increases Insulin Sensitivity and Improves Oxidant Metabolism through the CaMKKbeta-AMPK Pathway in PA-Induced IR C2C12 Cells. Scientific Reports. 7: 13248. PMID 29038536 DOI: 10.1038/s41598-017-13251-0  0.32
2017 Chen X, Zhao X, Cai H, Sun H, Hu Y, Huang X, Kong W, Kong W. The role of sodium hydrosulfide in attenuating the aging process via PI3K/AKT and CaMKKβ/AMPK pathways. Redox Biology. 12: 987-1003. PMID 28499253 DOI: 10.1016/j.redox.2017.04.031  0.32
2017 Cao Y, Wu X, Yang R, Wang X, Sun H, Lee I. Self-assembling Study of Sarcolipin and Its Mutants in Multiple Molecular Dynamic Simulations. Proteins. PMID 28241400 DOI: 10.1002/prot.25273  0.48
2017 Li X, Huang K, Zhang Q, Zhou J, Sun H, Tang F, Zhou H, Hu T, Wang S, Jia Y, Yang R, Chen Y, Cheng X, Lv W, Wu L, et al. Genome-wide association study identifies four SNPs associated with response to platinum-based neoadjuvant chemotherapy for cervical cancer. Scientific Reports. 7: 41103. PMID 28120872 DOI: 10.1038/srep41103  0.48
2016 Yang CY, Phillips JG, Stuckey JA, Bai L, Sun H, Delproposto J, Brown WC, Chinnaswamy K. Buried Hydrogen Bond Interactions Contribute to the High Potency of Complement Factor D Inhibitors. Acs Medicinal Chemistry Letters. 7: 1092-1096. PMID 27994744 DOI: 10.1021/acsmedchemlett.6b00299  0.36
2016 Qiao J, Li X, Wu Y, Wu X, Zhu F, Liu N, Qi K, Cheng H, Li D, Sun H, Zeng L, Xu K. An increased expression profile of Th9/IL-9 correlated with Th17/IL-17 in patients with immune thrombocytopenia. Platelets. 1-8. PMID 27662073 DOI: 10.1080/09537104.2016.1218454  0.36
2016 Li X, Huang K, Zhang Q, Shen J, Zhou H, Yang R, Wang L, Liu J, Zhang J, Sun H, Jia Y, Du X, Wang H, Deng S, Ding T, et al. Early response to neoadjuvant chemotherapy can help predict long-term survival in patients with cervical cancer. Oncotarget. PMID 27557523 DOI: 10.18632/oncotarget.11460  0.48
2016 Cao Y, Wu X, Wang X, Sun H, Lee I. Transmembrane dynamics of the Thr-5 phosphorylated Sarcolipin pentameric channel. Archives of Biochemistry and Biophysics. PMID 27378083 DOI: 10.1016/j.abb.2016.06.016  0.44
2016 Sun H, Tang F, Zhou S, Li X, Wang S, Huang K, Jia Y, Tian X, Ma D, Li S. Association between vascular endothelial growth factor expression and lymph node metastasis in cervical cancer: A meta-analysis. The Journal of Obstetrics and Gynaecology Research. PMID 27334572 DOI: 10.1111/jog.13064  0.32
2016 Huang K, Sun H, Chen Z, Li X, Wang S, Zhao X, Tang F, Jia Y, Hu T, Du X, Wang H, Lu Z, Huang J, Gui J, Wang X, et al. Optimal pathological response indicated better long-term outcome among patients with stage IB2 to IIB cervical cancer submitted to neoadjuvant chemotherapy. Scientific Reports. 6: 28278. PMID 27325186 DOI: 10.1038/srep28278  0.32
2016 Chen Z, Huang K, Lu Z, Deng S, Xiong J, Huang J, Li X, Tang F, Wang Z, Sun H, Wang L, Zhou S, Wang X, Jia Y, Hu T, et al. Risk model in stage IB1-IIB cervical cancer with positive node after radical hysterectomy. Oncotargets and Therapy. 9: 3171-9. PMID 27313462 DOI: 10.2147/OTT.S94151  0.32
2016 Huang K, Sun H, Li X, Hu T, Yang R, Wang S, Jia Y, Chen Z, Tang F, Shen J, Qin X, Zhou H, Yang R, Gui J, Wang L, et al. Prognostic risk model development and prospective validation among patients with cervical cancer stage IB2 to IIB submitted to neoadjuvant chemotherapy. Scientific Reports. 6: 27568. PMID 27279023 DOI: 10.1038/srep27568  0.32
2016 Li S, Li X, Zhang Y, Zhou H, Tang F, Jia Y, Hu T, Sun H, Yang R, Chen Y, Cheng X, Lv W, Wu L, Zhou J, Wang S, et al. Development and validation of a surgical-pathologic staging and scoring system for cervical cancer. Oncotarget. PMID 27014971 DOI: 10.18632/oncotarget.8245  0.32
2016 Zhou J, Li X, Huang K, Jia Y, Tang F, Sun H, Zhang Y, Zhang Q, Ma D, Li S. Young Cervical Cancer Patients May Be More Responsive than Older Patients to Neoadjuvant Chemotherapy Followed by Radical Surgery. Plos One. 11: e0149534. PMID 26901776 DOI: 10.1371/journal.pone.0149534  0.32
2015 Huang K, Li X, Yang R, Shen J, Chen Z, Qin X, Wang S, Jia Y, Tang F, Zhou H, Sun H, Zhou J, Guo L, Wang L, Qiao L, et al. Prospective cohort study to evaluate the efficacy of taxane plus platinum and CPT-11plus platinum regimes and to identify prognostic risk factors in cervical cancer patients. International Journal of Clinical and Experimental Medicine. 8: 15018-15029. PMID 26628986  0.48
2015 Wang S, Sun H, Jia Y, Tang F, Zhou H, Li X, Zhou J, Huang K, Zhang Q, Hu T, Yang R, Wang C, Xi L, Deng D, Wang H, et al. Association of 42 SNPs with genetic risk for cervical cancer: an extensive meta-analysis. Bmc Medical Genetics. 16: 25. PMID 25928231 DOI: 10.1186/s12881-015-0168-z  0.48
2015 Guo L, Liu X, Wang L, Sun H, Huang K, Li X, Tang F, Li S, Yuan X, Wang C. Outcome of international Federation of gynecology and obstetrics stage IIb cervical cancer from 2003 to 2012: an evaluation of treatments and prognosis: a retrospective study. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. 25: 910-8. PMID 25867278 DOI: 10.1097/IGC.0000000000000430  0.44
2015 Li X, Zhou J, Huang K, Tang F, Zhou H, Wang S, Jia Y, Sun H, Ma D, Li S. The predictive value of serum squamous cell carcinoma antigen in patients with cervical cancer who receive neoadjuvant chemotherapy followed by radical surgery: a single-institute study. Plos One. 10: e0122361. PMID 25860888 DOI: 10.1371/journal.pone.0122361  0.44
2015 Yang R, Li X, Zhou H, Jia Y, Zhou J, Huang K, Tang F, Hu T, Shen J, Chen Z, Wang S, Sun H, Guo L, Wang L, Wang H, et al. Establishment of a cervical cancer bio-bank for the Chinese population: from project-based sample collection to routine management. Archives of Gynecology and Obstetrics. 292: 399-404. PMID 25631341 DOI: 10.1007/s00404-015-3622-4  0.48
2014 Sun H, Lu J, Liu L, Yang CY, Wang S. Potent and selective small-molecule inhibitors of cIAP1/2 proteins reveal that the binding of Smac mimetics to XIAP BIR3 is not required for their effective induction of cell death in tumor cells. Acs Chemical Biology. 9: 994-1002. PMID 24521431 DOI: 10.1021/cb400889a  0.44
2014 Lu R, Zhou X, Ji W, Luo Y, Yang G, Sun H, Ge L, Jiang T, Li Y. [Dynamic changes of peripheral blood monocyte subsets after myocardial ischemia/reperfusion in rats]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi = Chinese Journal of Cellular and Molecular Immunology. 30: 131-4. PMID 24491050  0.32
2013 Chen Z, Li S, Huang K, Zhang Q, Wang J, Li X, Hu T, Wang S, Yang R, Jia Y, Sun H, Tang F, Zhou H, Shen J, Ma D, et al. The nuclear protein expression levels of SNAI1 and ZEB1 are involved in the progression and lymph node metastasis of cervical cancer via the epithelial-mesenchymal transition pathway. Human Pathology. 44: 2097-105. PMID 23791009 DOI: 10.1016/j.humpath.2013.04.001  0.48
2013 Sheng R, Sun H, Liu L, Lu J, McEachern D, Wang G, Wen J, Min P, Du Z, Lu H, Kang S, Guo M, Yang D, Wang S. A potent bivalent Smac mimetic (SM-1200) achieving rapid, complete, and durable tumor regression in mice. Journal of Medicinal Chemistry. 56: 3969-79. PMID 23651223 DOI: 10.1021/jm400216d  0.44
2013 Luo Y, Zhou X, Ji W, Sun H, Lu R, Jiang T, Li Y. [Inhibitory effect of NaV1.9 gene silencing on proliferation, phagocytosis and migration in RAW264.7 cells]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi = Chinese Journal of Cellular and Molecular Immunology. 29: 225-8. PMID 23643074  0.32
2013 Zeng L, An L, Fang T, Pan B, Sun H, Chen C, Cao J, Li Z, Xu K. A murine model of hepatic veno-occlusive disease induced by allogeneic hematopoietic stem cell transplantation. Cell Biochemistry and Biophysics. 67: 939-48. PMID 23579582 DOI: 10.1007/s12013-013-9587-7  0.36
2012 Wang S, Bai L, Lu J, Liu L, Yang CY, Sun H. Targeting inhibitors of apoptosis proteins (IAPs) for new breast cancer therapeutics. Journal of Mammary Gland Biology and Neoplasia. 17: 217-28. PMID 23054134 DOI: 10.1007/s10911-012-9265-1  0.44
2012 Bai L, McEachern D, Yang CY, Lu J, Sun H, Wang S. LRIG1 modulates cancer cell sensitivity to Smac mimetics by regulating TNFα expression and receptor tyrosine kinase signaling. Cancer Research. 72: 1229-38. PMID 22241084 DOI: 10.1158/0008-5472.CAN-11-2428  0.44
2012 Peng Y, Sun H, Lu J, Liu L, Cai Q, Shen R, Yang CY, Yi H, Wang S. Bivalent Smac mimetics with a diazabicyclic core as highly potent antagonists of XIAP and cIAP1/2 and novel anticancer agents. Journal of Medicinal Chemistry. 55: 106-14. PMID 22148838 DOI: 10.1021/jm201072x  0.44
2011 Kou S, Pan L, van Noort D, Meng G, Wu X, Sun H, Xu J, Lee I. A multishear microfluidic device for quantitative analysis of calcium dynamics in osteoblasts. Biochemical and Biophysical Research Communications. 408: 350-5. PMID 21514277 DOI: 10.1016/j.bbrc.2011.04.044  0.48
2011 Sun H, Liu L, Lu J, Bai L, Li X, Nikolovska-Coleska Z, McEachern D, Yang CY, Qiu S, Yi H, Sun D, Wang S. Potent bivalent Smac mimetics: effect of the linker on binding to inhibitor of apoptosis proteins (IAPs) and anticancer activity. Journal of Medicinal Chemistry. 54: 3306-18. PMID 21462933 DOI: 10.1021/jm101651b  0.44
2011 Cai Q, Sun H, Peng Y, Lu J, Nikolovska-Coleska Z, McEachern D, Liu L, Qiu S, Yang CY, Miller R, Yi H, Zhang T, Sun D, Kang S, Guo M, et al. A potent and orally active antagonist (SM-406/AT-406) of multiple inhibitor of apoptosis proteins (IAPs) in clinical development for cancer treatment. Journal of Medicinal Chemistry. 54: 2714-26. PMID 21443232 DOI: 10.1021/jm101505d  0.44
2011 Lu J, McEachern D, Sun H, Bai L, Peng Y, Qiu S, Miller R, Liao J, Yi H, Liu M, Bellail A, Hao C, Sun SY, Ting AT, Wang S. Therapeutic potential and molecular mechanism of a novel, potent, nonpeptide, Smac mimetic SM-164 in combination with TRAIL for cancer treatment. Molecular Cancer Therapeutics. 10: 902-14. PMID 21372226 DOI: 10.1158/1535-7163.MCT-10-0864  0.44
2011 Yang J, McEachern D, Li W, Davis MA, Li H, Morgan MA, Bai L, Sebolt JT, Sun H, Lawrence TS, Wang S, Sun Y. Radiosensitization of head and neck squamous cell carcinoma by a SMAC-mimetic compound, SM-164, requires activation of caspases. Molecular Cancer Therapeutics. 10: 658-69. PMID 21282353 DOI: 10.1158/1535-7163.MCT-10-0643  0.44
2010 Sun H, Lu J, Liu L, Yi H, Qiu S, Yang CY, Deschamps JR, Wang S. Nonpeptidic and potent small-molecule inhibitors of cIAP-1/2 and XIAP proteins. Journal of Medicinal Chemistry. 53: 6361-7. PMID 20684551 DOI: 10.1021/jm100487z  0.44
2010 Sun H, Liu L, Lu J, Qiu S, Yang CY, Yi H, Wang S. Cyclopeptide Smac mimetics as antagonists of IAP proteins. Bioorganic & Medicinal Chemistry Letters. 20: 3043-6. PMID 20443226 DOI: 10.1016/j.bmcl.2010.03.114  0.44
2009 Yang CY, Sun H, Chen J, Nikolovska-Coleska Z, Wang S. Importance of ligand reorganization free energy in protein-ligand binding-affinity prediction. Journal of the American Chemical Society. 131: 13709-21. PMID 19736924 DOI: 10.1021/ja9039373  0.44
2009 Sun W, Nikolovska-Coleska Z, Qin D, Sun H, Yang CY, Bai L, Qiu S, Wang Y, Ma D, Wang S. Design, synthesis, and evaluation of potent, nonpeptidic mimetics of second mitochondria-derived activator of caspases. Journal of Medicinal Chemistry. 52: 593-6. PMID 19138149 DOI: 10.1021/jm801101z  0.44
2008 Lee I, Sun H, Song J, Zhang Y. Kinetics of the nanohydrogel flattening at a hydrophobic interface. Journal of Nanoscience and Nanotechnology. 8: 3386-91. PMID 19051884  0.48
2008 Peng Y, Sun H, Nikolovska-Coleska Z, Qiu S, Yang CY, Lu J, Cai Q, Yi H, Kang S, Yang D, Wang S. Potent, orally bioavailable diazabicyclic small-molecule mimetics of second mitochondria-derived activator of caspases. Journal of Medicinal Chemistry. 51: 8158-62. PMID 19049347 DOI: 10.1021/jm801254r  0.44
2008 Zhang B, Nikolovska-Coleska Z, Zhang Y, Bai L, Qiu S, Yang CY, Sun H, Wang S, Wu Y. Design, synthesis, and evaluation of tricyclic, conformationally constrained small-molecule mimetics of second mitochondria-derived activator of caspases. Journal of Medicinal Chemistry. 51: 7352-5. PMID 19012392 DOI: 10.1021/jm801146d  0.44
2008 Lu J, Bai L, Sun H, Nikolovska-Coleska Z, McEachern D, Qiu S, Miller RS, Yi H, Shangary S, Sun Y, Meagher JL, Stuckey JA, Wang S. SM-164: a novel, bivalent Smac mimetic that induces apoptosis and tumor regression by concurrent removal of the blockade of cIAP-1/2 and XIAP. Cancer Research. 68: 9384-93. PMID 19010913 DOI: 10.1158/0008-5472.CAN-08-2655  0.44
2008 Sun H, Stuckey JA, Nikolovska-Coleska Z, Qin D, Meagher JL, Qiu S, Lu J, Yang CY, Saito NG, Wang S. Structure-based design, synthesis, evaluation, and crystallographic studies of conformationally constrained Smac mimetics as inhibitors of the X-linked inhibitor of apoptosis protein (XIAP). Journal of Medicinal Chemistry. 51: 7169-80. PMID 18954041 DOI: 10.1021/jm8006849  0.44
2008 Sun H, Nikolovska-Coleska Z, Yang CY, Qian D, Lu J, Qiu S, Bai L, Peng Y, Cai Q, Wang S. Design of small-molecule peptidic and nonpeptidic Smac mimetics. Accounts of Chemical Research. 41: 1264-77. PMID 18937395 DOI: 10.1021/ar8000553  0.44
2007 Sun H, Nikolovska-Coleska Z, Lu J, Meagher JL, Yang CY, Qiu S, Tomita Y, Ueda Y, Jiang S, Krajewski K, Roller PP, Stuckey JA, Wang S. Design, synthesis, and characterization of a potent, nonpeptide, cell-permeable, bivalent Smac mimetic that concurrently targets both the BIR2 and BIR3 domains in XIAP. Journal of the American Chemical Society. 129: 15279-94. PMID 17999504 DOI: 10.1021/ja074725f  0.44
2006 Sun H, Nikolovska-Coleska Z, Lu J, Qiu S, Yang CY, Gao W, Meagher J, Stuckey J, Wang S. Design, synthesis, and evaluation of a potent, cell-permeable, conformationally constrained second mitochondria derived activator of caspase (Smac) mimetic. Journal of Medicinal Chemistry. 49: 7916-20. PMID 17181177 DOI: 10.1021/jm061108d  0.44
2005 Sun H, Nikolovska-Coleska Z, Chen J, Yang CY, Tomita Y, Pan H, Yoshioka Y, Krajewski K, Roller PP, Wang S. Structure-based design, synthesis and biochemical testing of novel and potent Smac peptido-mimetics. Bioorganic & Medicinal Chemistry Letters. 15: 793-7. PMID 15664859 DOI: 10.1016/j.bmcl.2004.11.008  0.44
2004 Sun H, Nikolovska-Coleska Z, Yang CY, Xu L, Liu M, Tomita Y, Pan H, Yoshioka Y, Krajewski K, Roller PP, Wang S. Structure-based design of potent, conformationally constrained Smac mimetics. Journal of the American Chemical Society. 126: 16686-7. PMID 15612682 DOI: 10.1021/ja047438+  0.44
2004 Sun H, Nikolovska-Coleska Z, Yang CY, Xu L, Tomita Y, Krajewski K, Roller PP, Wang S. Structure-based design, synthesis, and evaluation of conformationally constrained mimetics of the second mitochondria-derived activator of caspase that target the X-linked inhibitor of apoptosis protein/caspase-9 interaction site. Journal of Medicinal Chemistry. 47: 4147-50. PMID 15293984 DOI: 10.1021/jm0499108  0.44
Show low-probability matches.